An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.

Löffler, L; Bauernfeind, A; Keyl, W; Hoffstedt, B; Piergies, A; Lenz, W

Löffler, L; Bauernfeind, A; Keyl, W; Hoffstedt, B; Piergies, A; Lenz, W.

Rev Infect Dis ; 8 Suppl 5: S593-8, 1986.

Article in En | MEDLINE | ID: mdl-3026009

Subject(s)

Ampicillin/therapeutic use; Bacterial Infections/drug therapy; Cefotaxime/therapeutic use; Penicillanic Acid/therapeutic use; Acute Disease; Adolescent; Adult; Aged; Arthritis, Infectious/drug therapy; Drug Combinations/therapeutic use; Female; Humans; Male; Middle Aged; Osteomyelitis/drug therapy; Random Allocation; Recurrence; Skin Diseases, Infectious/drug therapy; Sulbactam

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Infections / Cefotaxime / Penicillanic Acid / Ampicillin Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Rev Infect Dis Year: 1986 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links